Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates

Repligen (RGEN) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +9.52%. A quarter ago, it was expected that this drug developer would post earnings of $0.4 per share when it actually produced earnings of $0.37, delivering a surprise of -7.5%.Over the last four quarters, the company ha ...